Evotec is a global biotechnology company with over 5,000 professionals operating across 17 locations in six countries. The company specializes in drug discovery and preclinical development, offering an integrated R&D value chain that spans from early-stage concept to advanced preclinical work.
The company operates across multiple therapeutic modalities, including small-molecule therapeutics and biotherapeutics. Just – Evotec Biologics, its dedicated business unit, focuses on the design, development and manufacturing of biologics. Evotec deploys proprietary next-generation technology platforms alongside deep disease expertise to support its R&D services.
The company works through flexible partnering models with pharmaceutical and biotechnology clients seeking to accelerate their own development timelines. Its service offering emphasizes speed and efficiency in translating scientific concepts into viable therapeutic candidates, with particular attention to making high-quality therapies both feasible and economically viable.
